Skip to main content
Clinical Trials/CTRI/2013/07/003793
CTRI/2013/07/003793
Completed
Phase 3

Comparative Evaluation of Safety and Efficacy of Hydrochlorothiazide CR with Hydrochlorothiazide and Chlorthalidone in patients with Stage I Essential Hypertension

Ipca Laboratories Ltd Mumbai0 sites54 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Ipca Laboratories Ltd Mumbai
Enrollment
54
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 12, 2015
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ipca Laboratories Ltd Mumbai

Eligibility Criteria

Inclusion Criteria

  • i)patients with Systolic Blood Pressure\-140\-159mmHg and Diastolic Blood Pressure\-90\-99mmHg

Exclusion Criteria

  • i)patients with secondary hypertension
  • ii) Patients with significant cardiovascular disease
  • iii)Patients with abnormal renal, liver function
  • iv)Patients currently uncontrolled on thiazide type diuretics
  • v)patients who have used another investigational agent/device within last 30 days prior to enrollment
  • vi) Patients taking concomitant medications known to alter the blood pressure or to affect the action of study drug
  • vii) Patients with known history of hypersensitivity to study drugs or other drugs of same chemical class
  • viii) Pregnant or lactating women or women of child\-bearing potential not practicing contraception

Outcomes

Primary Outcomes

Not specified

Similar Trials